| Stage | EYE | % of rev | COO | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $499M | 100.00% | $1.1B | 100.00% | COO ×2.14 |
| Gross profit | $290M | 58.23% | $712M | 66.77% | COO +8.5pp |
| Operating income | $21M | 4.27% | $222M | 20.82% | COO +16.6pp |
| Pre-tax income | $18M | 3.60% | $202M | 18.93% | COO +15.3pp |
| Net income | $12M | 2.49% | $433M | 40.59% | COO +38.1pp |
| Stage | EYE | COO | Gap · A − B |
|---|---|---|---|
| Revenue | $499M100.00% | $1.1B100.00% | COO ×2.14 |
| Gross profit | 58.23%$290M | 66.77%$712M | COO +8.5pp |
| Operating income | 4.27%$21M | 20.82%$222M | COO +16.6pp |
| Pre-tax income | 3.60%$18M | 18.93%$202M | COO +15.3pp |
| Net income |
| 2.49%$12M |
| 40.59%$433M |
| COO +38.1pp |
No shared counterparties.